SynCore Biotechnology Co Ltd (4192) — Cash Flow Quality Index
Latest as of December 2023:
-0.72x
SynCore Biotechnology Co Ltd (4192) has a Cash Flow Quality Index of -0.72x as of December 2023. Operating cash flow of NT$-30.14 Million is below net income of NT$41.62 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SynCore Biotechnology Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.72x
Operating CF / Net Income
Operating Cash Flow
NT$-30.14 Million
TWD
Net Income
NT$41.62 Million
TWD
Data as of
Dec 2023
Most recent filing
Annual Cash Flow Quality Index for SynCore Biotechnology Co Ltd (None–None)
Year-by-year earnings quality comparison for SynCore Biotechnology Co Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.